Company news

Energenesis Biomedical Co., Ltd. (TWSE:6657) news

Energenesis Biomedical Co., Ltd. news releases on 6ix. Latest, Oct 5, 2026: Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development…

View Energenesis Biomedical Co., Ltd. →

Press releases & updates

Energenesis Biomedical and Yoo Young Pharm Sign MOU for ENERGI-F703DFU Development and Commercialization in Korea

October 5, 2026

Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease

August 1, 2025